Ewing’s Sarcoma (EWS) has been reported in seven children with Down Syndrome (DS). To date, a detailed assessment of this solid tumor in DS patients is still missing. Here, we characterized a chemo-resistant mediastinal EWS in a 2-year-old DS child, the youngest ever reported case, by exploiting sequencing approaches. The tumor showed a neuroectodermal development driven by the EWSR1-FLI1 fusion. The inherited myeloperoxidase deficiency of the patient caused failure of neutrophil-mediated cell death and promoted genomic instability. In this context, the tumor underwent nearly genome-wide haploidization resulting in a massive overexpression of pro-inflammatory cytokines. Recruitment of defective neutrophils fostered the fast evolution of this EWS.

Impaired neutrophil-mediated cell death drives Ewing’s Sarcoma in a two years old child with Down Syndrome / S. Peirone, E. Tirtei, A. Campello, C. Parlato, S. Guarrera, K. Mareschi, E. Marini, S. Dorin Asaftei, L. Bertero, M. Papotti, F. Priante, S. Perrone, M. Cereda, F. Fagioli. - (2023 Aug 28).

Impaired neutrophil-mediated cell death drives Ewing’s Sarcoma in a two years old child with Down Syndrome

S. Peirone
Co-primo
;
M. Cereda
Co-ultimo
;
2023

Abstract

Ewing’s Sarcoma (EWS) has been reported in seven children with Down Syndrome (DS). To date, a detailed assessment of this solid tumor in DS patients is still missing. Here, we characterized a chemo-resistant mediastinal EWS in a 2-year-old DS child, the youngest ever reported case, by exploiting sequencing approaches. The tumor showed a neuroectodermal development driven by the EWSR1-FLI1 fusion. The inherited myeloperoxidase deficiency of the patient caused failure of neutrophil-mediated cell death and promoted genomic instability. In this context, the tumor underwent nearly genome-wide haploidization resulting in a massive overexpression of pro-inflammatory cytokines. Recruitment of defective neutrophils fostered the fast evolution of this EWS.
Settore BIO/11 - Biologia Molecolare
Settore MED/06 - Oncologia Medica
Settore MED/03 - Genetica Medica
28-ago-2023
https://www.medrxiv.org/content/10.1101/2023.05.30.23289664v2
File in questo prodotto:
File Dimensione Formato  
2023.05.30.23289664v2.full.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 3.36 MB
Formato Adobe PDF
3.36 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1050058
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact